“…Currently, methods for the detection of exogenous materials in tissue have been developed including fluorescence imaging, − positron emission tomography, magnetic resonance imaging, , and transmission electron microscopy. − However, these techniques lack the depth and coverage of molecular information in situ. Accordingly, it is essential to develop a method for simultaneous mapping of the distribution of NPs and their spatial metabolic effects, as this information is critical to understanding the mechanisms of nanomaterials-aided diagnosis and therapy. Mass spectrometry imaging (MSI) allows the visualization and quantitation of elements and molecules in complex biological systems with distinct features including high throughput, label-free, high sensitivity, and high spatial resolution. − MSI has become an indispensable tool for spatial metabolomics, which has broken through the limitation of obtaining the depth and coverage of molecular information in tissue. , While the application of mass spectrometry imaging is still limited by resolution, through technological advances, the resolution has been able to exceed that of suborgans and reach the level of a single cell .…”